Delivery Order SPE2DB22D3301-SPE2DB24FX8PB

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML. The $5,469.25 firm fixed-price delivery order has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML to the Defense Logistics Agency (DLA). The contract, valued at $1,787.22, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 19, 2024. This award is not associated with any set-aside designation, indicating open competition....
This federal contract award is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 26, 2022, with a ceiling value of $3,165.05 and an ultimate completion date of August 29, 2022. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $3,750.93. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 20, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, a pharmaceutical product, with a ceiling value of $3,486.18. The contract was awarded on September 27, 2022, with a completion date of September 28, 2022, and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, with a ceiling value of $1,933.30. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency awarded a $178.56 delivery order to Amerisourcebergen Drug Corp under an indefinite-delivery/indefinite-quantity contract vehicle. The order is for 4561523523 units of ofloxacin 0.3% eye drops to be delivered by July 18, 2023 from the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, which will serve as the prime contractor. The delivery order was awarded on a firm-fixed-price...
The Defense Logistics Agency awarded a $78,120 delivery order to Amerisourcebergen Drug Corporation for ofloxacin 0.3% eye drops. The firm fixed price order is under an existing Prime Vendor contract vehicle and calls for delivery to a location in Conshohocken, Pennsylvania by July 18, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime contractor for this order to supply the requested pharmaceutical products to the...
The Defense Logistics Agency awarded a $37,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ofloxacin 0.3% eye drops. As the prime contractor, Amerisourcebergen will deliver 5mL bottles of the ophthalmic solution to a location in Conshohocken, Pennsylvania by August 9, 2023 under the terms of the order. The parent company, Amerisourcebergen Corporation, will perform the contract through its corporate office division. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a $7,487.45 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 4561412022 units of 0.3% Ofloxacin ear drops in 5mL bottles. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 5-6, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FX8PB
    Delivery Order

This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,640.84 contract is for the delivery of Ofloxacin 0.3% ear drops, 5ml, to support DLA Troop Support Medical programs and facilities. No set aside designation was used. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services. In addition, the company holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, with a potential value of $750,000 through May 2024.

Generated 4/11/24, 9:31 AM